Left untreated, this viral disease can cause serious and costly health problems. Once a difficult-to-treat infection, chronic hepatitis C can now be cured by taking a regimen of daily pills for eight to 12 weeks that act directly against the virus. But there’s a hitch: This cure costs $25,000 or more per person

Quick Read

Settlement ensures care of 2,200 state prisoners with hepatitis C. Inmates will no longer be required to undergo drug or alcohol treatment as a precondition for care

Quick Read

Two Washington state insurers — Group Health Cooperative and BridgeSpan — are targeted in class-action lawsuits that claim the companies are unfairly rationing new drugs that can cure hepatitis C based on high cost, not medical need

Quick Read

All told, 33 states spent more than $1 billion to treat the disease with Gilead Sciences’ Sovaldi, according to data released Tuesday by Sens. Charles Grassley, R-Iowa, and Ron Wyden, D-Ore.

Quick Read

Researchers at the University of Pennsylvania Perelman School of Medicine analyzed the hepatitis C prescriptions from 2,342 patients in Maryland, Delaware, Pennsylvania and New Jersey that were submitted between November 2014 and April 2015 to a large specialty pharmacy that serves the region

Quick Read

Medicine spending in the U.S. rose at the highest rate since 2001, a new report shows. Americans filled 4.3 billion prescriptions and doled out nearly $374 billion on medicine in 2014, according to new data from the IMS Institute for Healthcare Informatics

Quick Read

Hepatitis C drug Sovaldi strains programs for the poor; Texas didn’t pay for it last year

Quick Read